---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-008318"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:04:20.757880+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aptevo secures $60M equity line with Yorkville, extends funding runway into 2029

## Summary
- Enters $60M Standby Equity Purchase Agreement with Yorkville; minimal fees, no warrants.
- Company has right to sell shares at 96% of lowest 3-day VWAP; capped at ~199,466 shares without approval.
- Fully leveraged facility plus cash on hand expected to extend funding into 2029.
- Proceeds to support pipeline including mipletamig (CD123xCD3) in Phase 1b/2 frontline AML trial.

## SEC filing metadata
- accession: 0001193125-26-008318
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000119312526008318/0001193125-26-008318-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000119312526008318/apvo-20260108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-008318
- JSON: https://secwatch.observer/filing/0001193125-26-008318.json
- Plain text: https://secwatch.observer/filing/0001193125-26-008318.txt

## Key facts
- Material Agreements
  Aptevo Therapeutics Inc. entered into Standby Equity Purchase Agreement with YA II PN, LTD. valued at up to $60.0 million (effective 2026-01-08).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: YA II PN, LTD.
  - Value: up to $60.0 million
  - Effective: 2026-01-08
  source text: On January 8, 2026, Aptevo Therapeutics Inc. (the "Company") entered into a Standby Equity Purchase Agreement (the "Purchase Agreement") with YA II PN, LTD., a Cayman Islands exempt limited company ("Yorkville"). Pursuant to the Purchase Agreement, the Company has the right, but not the obligation, to issue and sell to Yorkville from time to time (each such occurrence, an "Advance") up to $60.0 million (the "Commitment Amount") of the Company's common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671584/000119312526008318/0001193125-26-008318-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.